合生元益生菌治疗自发性高血压相关机制的代谢组学研究

张莉敏; 陈宇峰; 战莹; 武晓丹; 周玉虹

doi:10.3969/j.issn.1006-0111.2019.02.008

合生元益生菌治疗自发性高血压相关机制的代谢组学研究

doi: 10.3969/j.issn.1006-0111.2019.02.008

1.
复旦大学附属华东医院, 上海 200050
2.
原沈阳军区总医院, 辽宁沈阳 110016
3.
沈阳药科大学药学院, 辽宁沈阳 110016

基金项目: 辽宁省自然科学基金（20170540954）

Metabonomics study on the antihypertensive mechanism of lactobacillus and bifidobacterium in the spontaneous hypertensive rats

1.
Huadong Hospital Affiliated to Fudan University, Shanghai 200050, China
2.
General Hospital of Shenyang Military Area Command, Shenyang 110016, China
3.
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China

摘要: 目的应用代谢组学相关技术，从表观水平探索合生元制剂通过调节肠道菌群达到降压效应的可能作用机制。方法将14只自发性高血压大鼠随机分为2组，模型组和治疗组各7只，另取7只Wistar Kyoto大鼠作为对照组，采用超高效液相色谱-四级杆飞行时间串联质谱（UHPLC-Q-TOF/MS）技术对对照组、原发性高血压模型组和合生元制剂治疗组的大鼠模型回肠段进行代谢组学分析，筛选合生元制剂治疗自发性高血压的潜在生物学标志物。结果通过对代谢组学的分析，确定了对照组与模型组之间具有显著差异的27种代谢物。在这些代谢物中，与模型组相比，治疗组中溶血磷脂酰乙醇胺（LysoPE）和磷脂酰胆碱（PC）可以显著被重新调节。结论合生元制剂可以通过改变肠道微生物群的结构，调节LysoPE和PC相关信号通路，进而改善自发性高血压状态；代谢组学有助于从分子水平理解自发性高血压发病机制及合生元制剂的降压机制。
- 自发性高血压大鼠 /
- 代谢组 /
- 合生元 /
- 超高效液相色谱
Abstract: Objective To explore the possible mechanism of synergistic effect of synbiotic preparations by regulating intestinal flora to achieve antihypertensive effect by the metabolomics-related techniques. Methods Fourteen spontaneously hypertensive rats were randomly divided into two groups,7 rats in each of the model group and the treatment group,and another 7 Wistar Kyoto rats were used as the control group.Ileum metabolic profiling among the control group,Spontaneous hypertension model group and symbiotic treatment group were analyzed by ultra-high performance liquid chromatography coupled with tandem quadrupole time of flight mass spectrometry (UHPLC-Q-TOF MS).The potential biomarkers for the treatment of spontaneous hypertension were selected. Results In additional,27 metabolites with significant differences between the control and model group were identified by analysis of metabonomics.Among these metabolites,LysoPE and PC could be significantly re-regulated in the treatment group,compared with the model group. Conclusion Synbiotics could improve the status of spontaneous hypertension by changing the structure of the intestinal microbiota,regulating LysoPE and PC-related signaling pathways.Metabolomics could help to understand the pathogenesis of essential hypertension and the hypotensive mechanism of synbiotics at the molecular level.
- spontaneously hypertensive rats /
- metabolomics /
- synbiotics /
- UHPLC

[1]	中国高血压防治指南修订委员会. 中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):701-743.
[2]	ZHENG Y,YU Alexander D,et al. Metabolomics and incident hypertension among blacks:the atherosclerosis risk in communities study[J]. Hypertension,2013,62(2):398-403.
[3]	YANG T,SANTISTEBAN M M,RODRIGUEZ V,et al. Gut dysbiosis is linked to hypertension[J].Hypertension,2015,65(6):1331-1340.
[4]	NICHOLSON J K,LINDON J C,HOLMES E.Metabonomics:understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data[J]. Xenobiotica,1999,29(11):1181-1189.
[5]	SCHNACKENBERG L K B R. Monitoringthe health to disease continuumwith global metabolicprofilingandsystemsbiology[J]. Pharmacogenomics,2006,7(7):1077-1086.
[6]	AUSTDAL M,TANGERAS L H,SKRASTAD R B,et al. First trimester urine and serum metabolomics for prediction of preeclampsia and festational hypertension:a prospective screening study[J].Int J Mol Sci,2015,16(9):21520-21538.
[7]	RYU S B.Phospholipid-derived signaling mediated by phospholipase A in plants[J]. Trends Plant Sci,2004,9(5):229-235.
[8]	ROCK C O,JACKOWSKI S,CRONAN J E,et al.Lipid metabolism in prokaryotes[J]. Biochem Lip Lipoprot Membr, 1996:35-74.
[9]	ZHAO Q,LI X M,LIU H N,et al. Metabolic map of osthole and its effect on lipids[J]. Xenobiotica. 2018,48(3):285-299.

[1]	叶隽, 张辰雨, 周海峰. HPLC法在盐酸艾司洛尔注射液中有关物质含量测定的应用 . 药学实践与服务, 2026, 44(9): 477-482. doi: 10.12206/j.issn.2097-2024.202509049
[2]	黄欣, 杨茹洁, 秦峰, 张士莲, 吴莘, 尹小燕. 硫酸镁钠钾口服液在内镜肠道清洁准备中的效果 . 药学实践与服务, 2026, 44(2): 85-87, 102. doi: 10.12206/j.issn.2097-2024.202311049
[3]	范晓婷, 毛之凡, 刘健, 杨帆, 林厚文. 基于肝内胆管癌类器官模型的海洋微生物次级代谢产物抗癌活性的评价及其诱导癌细胞凋亡研究 . 药学实践与服务, 2026, 44(6): 280-288, 312. doi: 10.12206/j.issn.2097-2024.202603003
[4]	邓晓霞, 田泾, 苏健芬. 钠−葡萄糖协同转运蛋白2的基因组学研究进展及其抑制剂的临床应用 . 药学实践与服务, 2026, 44(5): 228-232. doi: 10.12206/j.issn.2097-2024.202302006
[5]	李倩, 王荣, 杨峰, 王晓锋, 尹东锋. 高原低氧对药物代谢的影响及机制研究进展 . 药学实践与服务, 2026, 44(6): 275-279. doi: 10.12206/j.issn.2097-2024.202403018
[6]	吴海韵, 杨甜, 张弛, 梁文仪, 苏娟. 气相色谱-离子迁移谱技术在中药研究中的应用进展 . 药学实践与服务, 2026, 44(7): 341-345, 357. doi: 10.12206/j.issn.2097-2024.202409007
[7]	万立志, 王境焓, 吴春蓉, 李玲. 基于代谢组学技术的烟酰胺协同两性霉素B抑制白念珠菌的作用机制研究 . 药学实践与服务, 2026, 44(1): 20-25. doi: 10.12206/j.issn.2097-2024.202307034
[8]	曹秀瑜, 金梦颍, 沈淑琦, 王辉, 洪战英. 细胞代谢组学在阿尔茨海默病药物研究中的应用 . 药学实践与服务, 2026, 44(): 1-8. doi: 10.12206/j.issn.2097-2024.202509026
[9]	张婷婷, 黄晶晶, 梁静蕾, 庞涛, 陈万生, 张凤. 基于超高效液相质谱联用技术分析不同产地桔梗皂苷类成分的差异 . 药学实践与服务, 2026, 44(4): 189-199, 208. doi: 10.12206/j.issn.2097-2024.202506026
[10]	徐璐璐, 刘爱军. 丹参白术方“异病同治”冠心病、血管性痴呆、特发性膜性肾病的网络药理学作用机制研究 . 药学实践与服务, 2025, 43(3): 143-150. doi: 10.12206/j.issn.2097-2024.202312027
[11]	刘琳琳, 钟桂香, 严佳, 周欣. 不同使用条件下固相萃取柱对复方甘草口服溶液吗啡含量测定的影响 . 药学实践与服务, 2025, 43(12): 599-602. doi: 10.12206/j.issn.2097-2024.202311012
[12]	史生辉, 刘潇, 陈栋, 暨迪军, 马倩, 卢永昌. 二维液相色谱法分离藏药木藤蓼的化学成分 . 药学实践与服务, 2025, 43(9): 443-448. doi: 10.12206/j.issn.2097-2024.202412065
[13]	舒飞, 孙蕊, 宋凯, 张元林, 闫家铭, 舒丽芯. 粉-液双室袋产品的综合评价 . 药学实践与服务, 2025, 43(2): 92-96. doi: 10.12206/j.issn.2097-2024.202312009
[14]	姜建芳, 王思平, 何新军. 硝苯地平在高血压孕妇中的药物毒性：基于FAERS数据库的真实世界研究 . 药学实践与服务, 2025, 43(6): 307-312. doi: 10.12206/j.issn.2097-2024.202501001
[15]	晁亮, 王辉, 沈淑琦, 游飘雪, 冀凯宏, 洪战英. 基于UHPLC-Q/TOF-MS代谢组学策略的葛根-知母药对防治阿尔茨海默病的药效与作用机制研究 . 药学实践与服务, 2025, 43(1): 30-40. doi: 10.12206/j.issn.2097-2024.202409035
[16]	徐尧, 马春辉, 李志勇. 高血压对大鼠心血管纤维化及sFRP2表达的影响 . 药学实践与服务, 2025, 43(4): 180-184. doi: 10.12206/j.issn.2097-2024.202409055
[17]	魏雨辰, 田家盛, 王道鑫, 凌期盛, 王治, 缪朝玉. 烟酰胺单核苷酸口服给药对高血压大鼠的影响 . 药学实践与服务, 2025, 43(5): 213-221. doi: 10.12206/j.issn.2097-2024.202412006
[18]	赵雪, 顾妍秋, 楚皓文, 吴彩胜, 李镐, 陈啸飞. 基于超高效液相色谱-四极杆飞行时间质谱的麻杏石甘汤化学成分分析 . 药学实践与服务, 2025, 43(11): 548-554, 571. doi: 10.12206/j.issn.2097-2024.202306028
[19]	毛智毅, 王筱燕, 陈晓颖, 汤逸斐. 度拉糖肽联合二甲双胍对肥胖型2型糖尿病患者机体代谢、体脂成分及血清脂肪因子的影响 . 药学实践与服务, 2024, 42(7): 305-309. doi: 10.12206/j.issn.2097-2024.202305032
[20]	孙丹倪, 黄勇, 张嘉宝, 王培. 代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049

点击查看大图

计量

文章访问数: 6691
HTML全文浏览量: 1337
PDF下载量: 341
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

合生元益生菌治疗自发性高血压相关机制的代谢组学研究

doi: 10.3969/j.issn.1006-0111.2019.02.008

Metabonomics study on the antihypertensive mechanism of lactobacillus and bifidobacterium in the spontaneous hypertensive rats

计量

合生元益生菌治疗自发性高血压相关机制的代谢组学研究

doi: 10.3969/j.issn.1006-0111.2019.02.008

1. 复旦大学附属华东医院, 上海 200050

2. 原沈阳军区总医院, 辽宁沈阳 110016

3. 沈阳药科大学药学院, 辽宁沈阳 110016

English Abstract

Metabonomics study on the antihypertensive mechanism of lactobacillus and bifidobacterium in the spontaneous hypertensive rats

1. Huadong Hospital Affiliated to Fudan University, Shanghai 200050, China

2. General Hospital of Shenyang Military Area Command, Shenyang 110016, China

3. School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China

全文HTML

目录

留言板

合生元益生菌治疗自发性高血压相关机制的代谢组学研究

doi: 10.3969/j.issn.1006-0111.2019.02.008

Metabonomics study on the antihypertensive mechanism of lactobacillus and bifidobacterium in the spontaneous hypertensive rats

计量

出版历程

合生元益生菌治疗自发性高血压相关机制的代谢组学研究

doi: 10.3969/j.issn.1006-0111.2019.02.008

1. 复旦大学附属华东医院, 上海 200050 2. 原沈阳军区总医院, 辽宁 沈阳 110016 3. 沈阳药科大学药学院, 辽宁 沈阳 110016

English Abstract

Metabonomics study on the antihypertensive mechanism of lactobacillus and bifidobacterium in the spontaneous hypertensive rats

1. Huadong Hospital Affiliated to Fudan University, Shanghai 200050, China 2. General Hospital of Shenyang Military Area Command, Shenyang 110016, China 3. School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China

全文HTML

目录

1. 复旦大学附属华东医院, 上海 200050

2. 原沈阳军区总医院, 辽宁沈阳 110016

3. 沈阳药科大学药学院, 辽宁沈阳 110016

1. Huadong Hospital Affiliated to Fudan University, Shanghai 200050, China

2. General Hospital of Shenyang Military Area Command, Shenyang 110016, China

3. School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China